The Discriminative Effects of Tramadol in Humans

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Opioid Abuse, Opioid Addiction, Stimulant Abuse, Stimulant Addiction

In brief

This research is part of a set of studies whose purpose is to test whether tramadol can be used for the treatment of opioid addiction. Tramadol is already available in the United States as a pain medicine marketed as Ultram. It has effects similar to morphine, and it may also have effects similar to other drugs like stimulants. The doses of tramadol used in this study are higher than those generally used for the treatment of pain. To be in this study a participant must be a user of opioids (drugs like heroin) and stimulants (drugs like cocaine), but cannot be addicted to either. The person must be between 21-55 years old, and generally healthy. Up to 12 people will take part in this study.

Key facts

Study ID
NCT00499746
Run by
National Institute on Drug Abuse (NIDA)
People needed
20
Starts
2007-11-01
Expected to finish
2011-08-01
Last updated by the study team
2017-10-17

Who can join

Age: 2 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.